Submitted by Anonymous (not verified) on 25 March 2026 - 16:33 Orphan designation: navtemadlin Treatment of myelofibrosis, 09/01/2026 Positive Link: https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-25-3178Source: What's new